Equillium Newsroom

Analysts Have Conflicting Sentiments on These Healthcare Companies: Equillium (EQ), Quest Diagnostics (DGX) and Alnylam Pharma (ALNY)

TipRanksNov 5 01:22 ET

Stifel Maintains Equillium(EQ.US) With Buy Rating, Cuts Target Price to $2

Moomoo NewsNov 4 21:34 ET

Equillium Cut to Hold From Buy by Jones Trading

Dow JonesNov 1 07:04 ET

Equillium Analyst Ratings

BenzingaNov 1 06:55 ET

JonesTrading Downgrades Equillium(EQ.US) to Hold Rating

Moomoo NewsOct 31 17:31 ET

Equillium Analyst Ratings

BenzingaAug 19 07:12 ET

Analysts Offer Insights on Healthcare Companies: Equillium (EQ), Foghorn Therapeutics (FHTX) and Immix Biopharma, Inc. (IMMX)

TipRanksAug 19 06:42 ET

H.C. Wainwright Maintains Equillium(EQ.US) With Buy Rating, Maintains Target Price $5

Moomoo NewsAug 19 06:31 ET

Analysts' Top Healthcare Picks: AC Immune SA (ACIU), Equillium (EQ)

TipRanksAug 9 05:52 ET

Equillium Analyst Ratings

BenzingaJun 5 07:20 ET

Equillium Analyst Ratings

BenzingaMay 17 10:11 ET

Buy Rating Affirmed for Equillium on Milestones and Financial Prospects

TipRanksMay 17 06:20 ET

Buy Rating on Equillium as Promising Trials and Financial Stability Signal Upside Potential

TipRanksMay 14 04:41 ET

Buy Rating Affirmed for Equillium on Strong Itolizumab Data and Promising EQ101 Phase 2 Prospects

TipRanksMay 8 06:35 ET

Buy Rating Affirmed for Equillium on Strong Clinical Data and Potential Financial Upsides

TipRanksApr 3 01:50 ET

Equillium Analyst Ratings

BenzingaApr 2 08:57 ET

Buy Rating Reaffirmed for Equillium on Strong Itolizumab Trial Results and Positive Financial Outlook

TipRanksApr 2 06:30 ET

Buy Rating Affirmed for Equillium Amid Promising Clinical Trials and Potential Financial Upsides

TipRanksMar 27 03:01 ET

HC Wainwright & Co. Maintains Buy on Equillium, Lowers Price Target to $4

BenzingaDec 26, 2023 06:22 ET

Equillium Analyst Ratings

BenzingaDec 26, 2023 06:21 ET